Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
最高法院關於普渡製藥公司60億美元阿片類藥物和解協議和薩克勒家族豁免的裁決迫在眉睫
The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in the balance as the U.S. Supreme Court prepares to hear arguments on Monday.
在美國最高法院準備在週一聽取辯論之際，涉及強效且令人上癮的止痛藥奧施康定的製造商普渡製藥公司的60億美元破產協議的命運懸而未決。
The settlement, which aims to address the devastating opioid epidemic, has been met with mixed reactions, with some praising its potential to provide much-needed relief while others criticize the immunity it grants the Sackler family, Purdue's wealthy owners.
該和解協議旨在應對毀滅性的阿片類藥物流行，但反應不一，有人稱讚它有可能提供急需的救濟，而另一些人則批評它賦予普渡大學富有的所有者薩克勒家族的豁免權。
Multi-billion-dollar Agreement At Stake
數十億美元的協議岌岌可危
If approved by the Supreme Court, the settlement would allocate billions of dollars to addiction treatment and other...
如果獲得最高法院的批准，該和解協議將...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。